VCIM
DTIL icon

Velan Capital Investment Management’s Precision BioSciences DTIL Stock Holding History

Velan Capital Investment Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$220K Buy
40,000
+20,000
+100% +$92.3K 0.14% 36
2025
Q4 		$83.2K Hold
20,000
– – 0.05% 44
2025
Q3 		$110K Buy
+20,000
New +$95.8K 0.1% 40

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Velan Capital Investment Management's DTIL Position: Q1 2026 in Review

Velan Capital Investment Management increased its Precision BioSciences (DTIL) stake by 100% in Q1 2026, buying an estimated $92.3K and bringing the position to 40,000 shares worth $220K. The position accounts for 0.14% of the portfolio, ranked #36.

Velan Capital Investment Management first reported a position in DTIL in Q3 2025 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Velan Capital Investment Management held 40,000 shares of Precision BioSciences worth $220K as of Q1 2026.
  • Velan Capital Investment Management bought 20,000 Precision BioSciences shares in Q1 2026, an estimated $92.3K.
  • Precision BioSciences made up 0.14% of Velan Capital Investment Management's portfolio in Q1 2026, its #36 holding.
  • Velan Capital Investment Management first reported a position in Precision BioSciences in Q3 2025 and has held it in 3 quarters since.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.